CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment of $0 for the 12-month period ending 2018-12-29, per its 10-K filed 2019-02-13.
Discontinued › Income Statement › Other Income
us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments · last filed 2019-02-13
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2018 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2016 was $279.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2015 was $0.00.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 12 month |
|---|---|
| 2018-12-29 | $0.00 10-K · filed 2019-02-13 |
| 2017-12-30 | $0.00 10-K · filed 2019-02-13 |
| 2016-12-31 | $279.00K 10-K · filed 2019-02-13 |
| 2015-12-26 | $0.00 10-K · filed 2018-02-13 |
| 2011-12-31 | $0.00 10-K · filed 2012-02-27 |
| 2010-12-25 | $0.00 10-K · filed 2012-02-27 |
| 2009-12-26 | $674.00K 10-K · filed 2012-02-27 |
| 2008-12-27 | $3.28M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |